ABOS
Acumen Pharmaceuticals, Inc.—15-min delayed · EOD close3.10 +6.16% upas of 2026-09-02mkt cap $224M
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001576885
Quality score
—/100
Growth25
missing: revenueGrowth
Business qualityno data
missing: grossMargin, operatingMargin, netMargin
Financial health82
Valuationno data
missing: peRatio, psRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
Revenue growth
—
year over year
Earnings growth
-2.7%
year over year
Gross margin
—
Operating margin
—
Net margin